American Healthcare REIT (NYSE:AHR) Given New $71.00 Price Target at UBS Group

American Healthcare REIT (NYSE:AHR) had its price objective lifted by analysts at UBS Group from $62.00 to $71.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group‘s target price suggests a potential upside of 19.89% from the company’s current price.

Several other brokerages have also issued reports on AHR. Zacks Research upgraded shares of American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 2nd. Citigroup boosted their price objective on shares of American Healthcare REIT from $65.00 to $67.00 and gave the stock a “buy” rating in a research note on Tuesday. Compass Point began coverage on shares of American Healthcare REIT in a report on Tuesday, July 21st. They issued a “buy” rating and a $70.00 price objective on the stock. Barclays decreased their target price on shares of American Healthcare REIT from $66.00 to $60.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. Finally, KeyCorp raised their target price on shares of American Healthcare REIT from $58.00 to $68.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Two investment analysts have rated the stock with a Strong Buy rating and thirteen have assigned a Buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $64.00.

American Healthcare REIT Stock Down 0.3%

AHR stock traded down $0.17 during midday trading on Wednesday, hitting $59.22. The stock had a trading volume of 1,400,236 shares, compared to its average volume of 3,001,972. The business has a 50-day moving average of $53.24 and a two-hundred day moving average of $51.76. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.53 and a quick ratio of 0.48. The firm has a market cap of $12.91 billion, a price-to-earnings ratio of 120.86, a price-to-earnings-growth ratio of 1.40 and a beta of 0.78. American Healthcare REIT has a 52-week low of $44.81 and a 52-week high of $59.55.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.56 by $0.02. American Healthcare REIT had a return on equity of 2.38% and a net margin of 3.61%. The business had revenue of $742.15 million during the quarter, compared to analyst estimates of $703.51 million. During the same quarter last year, the firm posted $0.44 earnings per share. The company’s revenue for the quarter was up 29.5% on a year-over-year basis. As a group, equities research analysts forecast that American Healthcare REIT will post 2.25 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Mark Foster sold 2,000 shares of American Healthcare REIT stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $55.39, for a total value of $110,780.00. Following the completion of the transaction, the executive vice president owned 51,617 shares of the company’s stock, valued at $2,859,065.63. The trade was a 3.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Scott Estes sold 2,500 shares of the company’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $59.32, for a total transaction of $148,300.00. Following the completion of the transaction, the director owned 18,989 shares in the company, valued at approximately $1,126,427.48. The trade was a 11.63% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 6,000 shares of company stock valued at $337,170. 0.75% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Greenland Capital Management LP raised its holdings in American Healthcare REIT by 94.7% in the 2nd quarter. Greenland Capital Management LP now owns 185,000 shares of the company’s stock worth $9,648,000 after acquiring an additional 90,000 shares during the last quarter. WINTON GROUP Ltd purchased a new stake in American Healthcare REIT during the 2nd quarter valued at $1,377,000. Wellington Management Group LLP boosted its stake in American Healthcare REIT by 4.5% during the 2nd quarter. Wellington Management Group LLP now owns 8,658,850 shares of the company’s stock valued at $451,559,000 after purchasing an additional 375,063 shares during the last quarter. TD Waterhouse Canada Inc. boosted its stake in American Healthcare REIT by 25.6% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 291,978 shares of the company’s stock valued at $14,807,000 after purchasing an additional 59,425 shares during the last quarter. Finally, Squarepoint Ops LLC bought a new stake in shares of American Healthcare REIT in the 2nd quarter worth $19,546,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.